It is with this in mind that this preliminary study was conducted to determine the involvement of the Ser217Leu (C650T) and Ala541Thr (G1621A) variants of the ELAC2 gene in prostate cancer in the Burkinabe population. The gene discussed is ELAC2; the disease is prostate cancer.